Skip to content

February 2026

Anxiety

What February 2026's 25 new studies found, synthesized from the papers below. All Anxiety research →

The synthesis

Synthesized from 25 studies in the library · AI-generated, grounded in the abstracts below

Found by searching the library for Anxiety, generalized anxiety disorder, GAD, panic disorder, anxiety disorder, then ranked by relevance.

Research published in February 2026 indicates that mindfulness-based interventions, including meditation, mindful breathing, and MBSR, consistently reduce anxiety across student, clinical, and general populations, with meta-analyses showing moderate effects (Hedges' g ≈ -0.45 to -0.58). Psychedelic-assisted therapies (psilocybin, ketamine) also show large improvements in anxiety and related symptoms, though these findings come from open-label or retrospective studies with limited controls. The main caveats are small sample sizes, lack of blinding, and limited long-term follow-up data.

Evidence by study

Direction is which way each study's own result points, not our rating of the study.

What the directions mean
Supports:
the study found the intervention worked, or its hypothesis held.
Opposes:
it found the opposite, no benefit or a harm.
No effect:
no significant difference either way.
Mixed:
effects in both directions within the same study.
Unclear:
the abstract does not report a direction.

Group counseling with mindful breathing significantly reduced anxiety scores in the experimental group compared to control, with a large effect size (Cohen's d = 2.04).

pretest-posttest control group design Sample size: 20

Higher spirituality was inversely associated with depressive symptoms, but anxiety levels were highest among participants engaging in non-religious spiritual practices, with mixed correlations across groups.

cross-sectional study Sample size: 1240

Mindfulness-Based Interventions produced a moderate improvement in psychological outcomes (Hedges' g = -0.45), with stronger effects for anxiety (g = -0.56) than depression.

systematic review with meta-analysis Sample size: 24000

MBSR therapy significantly reduced anxiety levels in hemodialysis patients, as indicated by a Wilcoxon test (p = 0.000).

one-group pre-test post-test (quantitative) Sample size: 88

Psilocybin-assisted treatment was associated with significant and sustained improvements in PTLD symptom burden and quality of life at six months, with no serious adverse events.

open-label, single-arm pilot study Sample size: 20

Meditation and breathwork produced nearly opposite effects on self-report and biofield measures, with meditation lowering arousal and breathwork increasing arousal.

feasibility study Sample size: 23

Baseline depression and anxiety predicted more challenging psychedelic experiences but not mystical-type experiences, while baseline wellbeing predicted more mystical and less challenging experiences.

longitudinal study Sample size: 654

Yoga practice for three months significantly reduced DASS-21 scores and serum cortisol levels in participants with depression, anxiety, and stress.

pre-post intervention study Sample size: 120

Neuroticism positively predicted nightmare distress and negatively predicted social readjustment, while openness positively predicted both social readjustment and nightmare distress.

cross-sectional study Sample size: 205

The review argues that fluoxetine appears to attenuate the mind-altering effects of psilocybin, likely due to modulation of serotonin receptor activity.

review

The paper proposes that pathological anxiety and recurrent nightmares are functionally identical neurobiological states differing only in prefrontal gate status over the periaqueductal gray.

theoretical or philosophical paper

Participants considered psilocybin a much-needed alternative to traditional treatments for cancer-related depression and anxiety but felt its legal status was a significant barrier to access.

qualitative study Sample size: 7

The review finds that anxiety, chronic stress, and trauma exposure are strongly associated with increased frequency, severity, and distress in sleep paralysis episodes.

review

The paper argues that mindfulness in education can reduce stress, anxiety, and depression among students, enhancing emotional intelligence and resilience.

theoretical or philosophical paper

Psychedelic-assisted psychotherapy produced large to very large effects on depression and anxiety symptoms, with some evidence that two dosing sessions may be more effective than one.

systematic review and meta-analysis Sample size: 23

Dance Movement Therapy with Osho Kundalini music was associated with significant reductions in anxiety, stress, and depression symptoms among participants.

pre-experimental one-group pretest–posttest design Sample size: 15

Pragya Yoga significantly improved psychological well-being in young adults, with large effects in males and moderate-large effects in females.

randomized controlled trial Sample size: 83

The review finds that sleep disturbances are bidirectionally linked to PTSD symptoms, and sleep-focused interventions improve both sleep problems and core PTSD symptoms.

literature review

Integrating meditation into an online business course lowers students' reported stress and anxiety levels.

pre-post study

Chronic use of ayahuasca or cannabis was not associated with detectable lasting neuropsychological impairments, and personality characteristics most clearly distinguished chronic users from non-users.

cross-sectional study Sample size: 219

Greater mystical-type experiences during psilocybin sessions were associated with lower OCD symptom severity at 1- and 12-week follow-up.

exploratory analysis of data from a randomized, double-blind, placebo-controlled trial and subsequent open-label phase Sample size: 27

At-home ketamine-assisted therapy was associated with large reductions in PTSD symptoms, with 79.7% of patients showing clinical response and 60.7% achieving remission after six sessions.

retrospective cohort study Sample size: 374

Mindfulness-based interventions produce medium effects in reducing anxiety (g = -0.58) and depression (g = -0.51) among students.

systematic review and meta-analysis

The paper proposes that co-administering 5-MeO-DMT and THCV via a precision vaporization device may provide a more effective and tolerable treatment for TRD and anxiety disorders.

theoretical or philosophical paper

Active 8 Hz TI stimulation during meditation increased the reward positivity potential and reduced negative emotionality compared to sham.

within-subjects crossover trial Sample size: 19

Points of agreement

  • Mindfulness-based interventions (including meditation, mindful breathing, MBSR, and yoga) consistently reduce anxiety across diverse populations, with meta-analyses showing moderate effect sizes.
  • Psychedelic-assisted therapies (psilocybin, ketamine) show large improvements in anxiety and related symptoms, though often in open-label or retrospective designs.
  • Psychological factors such as anxiety, stress, and trauma are consistently linked to worse outcomes in sleep-related disturbances (e.g., nightmares, sleep paralysis).

Conflicts

  • One cross-sectional study found higher spirituality was associated with lower depressive symptoms but higher anxiety among those engaging in non-religious spiritual practices, while other studies generally show mindfulness and spiritual practices reduce anxiety.
  • The meta-analysis on psychedelic-assisted psychotherapy found some evidence for two dosing sessions being more effective than one, but this was not robust across analyses.
  • A study on chronic ayahuasca and cannabis users found no lasting neuropsychological impairments, contrasting with some previous findings associating cannabis with cognitive deficits.

Gaps

  • Most mindfulness and yoga studies lack long-term follow-up beyond a few months.
  • Psychedelic studies often have small sample sizes, open-label designs, and lack blinded assessments.
  • Few studies examine the durability of effects beyond 6 months.
  • There is limited research on the interaction between psychedelics and common psychiatric medications (e.g., SSRIs, benzodiazepines).
  • Many studies are conducted in specific populations (students, patients with chronic illness) limiting generalizability.
Browse these studies in the library